Evaluation of vascular tone and cardiac contractility in response to silver nanoparticles, using Langendorff rat heart preparation

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 13, Issue 4, 2017, Pages 1507-1518

  Ramirez Lee Manuel, Alejandro ^a   Martinez Cuevas, Pedro Pablo ^a   Rosas Hernandez, Hector ^a   Oros Ovalle, Cuauhtémoc ^b   Bravo Sanchez, Mariela ^c   Martinez Castañon, Gabriel Alejandro ^a   Gonzalez, Carmen ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b HOSPITAL CENTRAL DR IGNACIO MORONES PRIETO   (Mexico)

^c INSTITUTO POTOSINO DE INVESTIGACIÓN CIENTÍFICA Y TECNOLÓGICA   (Mexico)

Author keywords

Coronary vascular tone; Myocardial contractility; Nitric oxide; Oxidative stress; Silver nanoparticles

Indexed keywords

METAL NANOPARTICLES; NANOPARTICLES; NITRIC OXIDE; OXIDATIVE STRESS; PHYSIOLOGY; RATS; SILVER;

ANTI-MICROBIAL PROPERTIES; CARDIAC CONTRACTILITY; CARDIAC PHYSIOLOGY; LOW CONCENTRATIONS; MYOCARDIAL CONTRACTILITY; SILVER NANOPARTICLES; SILVER NANOPARTICLES (AGNPS); VASCULAR TONES;

HEART;

ACETYLCHOLINE; INDUCIBLE NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; SILVER NANOPARTICLE; METAL NANOPARTICLE; NITRIC OXIDE; NOS2 PROTEIN, RAT; SILVER;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CARDIAC MUSCLE; CARDIOTOXICITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HEART MUSCLE CONTRACTILITY; HEART TISSUE; ISOLATED HEART; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; RHABDOMYOLYSIS; VASOCONSTRICTION; ANIMAL; CHEMISTRY; DRUG EFFECTS; HEART; IN VITRO STUDY; METABOLISM; MUSCLE CONTRACTION; WISTAR RAT;

ANIMALS; HEART; IN VITRO TECHNIQUES; MALE; METAL NANOPARTICLES; MUSCLE CONTRACTION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; RATS, WISTAR; SILVER; VASOCONSTRICTION;

EID: 85017214062     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2017.01.017     Document Type: Article

References (60)

1. 1 Fiorino, D.J., Voluntary Initiatives, Regulation, and Nanotechnology Oversight: Charting a Path. Project on Emerging Nanotechnologies Publication 19. 2010.
2. 2 Yu, S.-j., Y-g, Yin, J-f, Liu, Silver nanoparticles in the environment. Evnviron Sci Process Impacts 15:1 (2013), 78–92.
3. 3 Bachler, G., von Goetz, N., Hungerbühler, K., A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles. Int J Nanomedicine 8 (2013), 3365–3382.
4. 4 Gonzalez, C., Rosas-Hernandez, H., Ramirez-Lee, M.A., Salazar-Garcia, S., Ali, S.F., Role of silver nanoparticles (AgNPs) on the cardiovascular system. Arch Toxicol 90:3 (2016), 493–511.
5. 5 Schulz, H., Harder, V., Ibald-Mulli, A., Khandoga, A., Koenig, W., Krombach, F., et al. Cardiovascular effects of fine and ultrafine particles. J Aerosol Med 18:1 (2005), 1–22.
6. 6 Rastaldo, R., Pagliaro, P., Cappello, S., Penna, C., Mancardi, D., Westerhof, N., et al. Nitric oxide and cardiac function. Life Sci 81:10 (2007), 779–793.
7. 7 Zhao, Y., Vanhoutte, P.M., Leung, S.W.S., Vascular nitric oxide: beyond eNOS. J Pharmacol Sci 129:2 (2015), 83–94.
8. 8 Rosas-Hernandez, H., Jimenez-Badillo, S., Martinez-Cuevas, P.P., Gracia-Espino, E., Terrones, H., Terrones, M., et al. Effects of 45-nm silver nanoparticles on coronary endothelial cells and isolated rat aortic rings. Toxicol Lett 191:2–3 (2009), 305–313.
9. 9 Raieszadeh, H., Noaman, V., Yadegari, M., Echocardiographic assessment of cardiac structural and functional indices in broiler chickens treated with silver nanoparticles. Scientific World Journal, 2013, 2013.
10. 10 Asharani, P., Wu, Y.L., Gong, Z., Valiyaveettil, S., Toxicity of silver nanoparticles in zebrafish models. Nanotechnology, 19(25), 2008, 255102.
11. 11 Chies, A.B., de Oliveira, A.M., Pereira, F.C., de Andrade, C.R., Correa, F.M., Phenylephrine-induced vasoconstriction of the rat superior mesenteric artery is decreased after repeated swimming. J Smooth Muscle Res 40:6 (2004), 249–258.
12. 12 Roberts, J.R., McKinney, W., Kan, H., Krajnak, K., Frazer, D.G., Thomas, T.A., et al. Pulmonary and cardiovascular responses of rats to inhalation of silver nanoparticles. J Toxicol Environ Health A 76:11 (2013), 651–668.
13. 13 Korani, M., Rezayat, S.M., Arbabi, Bidgoli S., Sub-chronic dermal toxicity of silver nanoparticles in Guinea pig: special emphasis to heart, bone and kidney toxicities. Iran J Pharm Res 12:3 (2013), 511–519.
14. 14 Bostan, H.B., Rezaee, R., Valokala, M.G., Tsarouhas, K., Golokhvast, K., Tsatsakis, A.M., et al. Cardiotoxicity of nano-particles. Life Sci, 2016.
15. 15 Taju, G., Abdul Majeed, S., Nambi, K.S.N., Sahul Hameed, A.S., In vitro assay for the toxicity of silver nanoparticles using heart and gill cell lines of Catla catla and gill cell line of Labeo rohita. Comp Biochem Physiol C Toxicol Pharmacol 161 (2014), 41–52.
16. 16 Ebabe Elle, R., Gaillet, S., Vide, J., Romain, C., Lauret, C., Rugani, N., et al. Dietary exposure to silver nanoparticles in Sprague–Dawley rats: effects on oxidative stress and inflammation. Food Chem Toxicol 60 (2013), 297–301.
17. 17 Stampfl, A., Maier, M., Radykewicz, R., Reitmeir, P., Gottlicher, M., Niessner, R., Langendorff heart: a model system to study cardiovascular effects of engineered nanoparticles. ACS Nano 5:7 (2011), 5345–5353.
18. 18 Yu, X., Hong, F., Zhang, Y.Q., Bio-effect of nanoparticles in the cardiovascular system. J Biomed Mater Res A 104:11 (2016), 2881–2897.
19. 19 Espinosa-Cristobal, L.F., Martinez-Castañon, G.A., Loyola-Rodriguez, J.P., Patiño-Marin, N., Reyes-Macías, J.F., Vargas-Morales, J.M., et al. Toxicity, distribution, and accumulation of silver nanoparticles in Wistar rats. J Nanopart Res 15:6 (2013), 1–12.
20. 20 Li, Y., Yang, Q., Li, M., Song, Y., Rate-dependent interface capture beyond the coffee-ring effect. Sci Rep, 6, 2016, 24628.
21. 21 Herrera-Gomez, A., Ceballos-Sanchez, O., Vazquez-Lepe, M.O., Practical methods for background subtraction in photoemission spectra: surf. Interface Anal 46 (2014), 897–905.
22. 22 Herrera-Gomez, A., A Double Lorentzian Shape for Asymmetric Photoelectron Peaks Internal Report. 2011, CINVESTAV, Queretaro.
23. 23 Skrzypiec-Spring, M., Grotthus, B., Szelag, A., Schulz, R., Isolated heart perfusion according to Langendorff-still viable in the new millennium. J Pharmacol Toxicol Methods 55:2 (2007), 113–126.
24. 24 Gonzalez, C., Corbacho, A.M., Eiserich, J.P., Garcia, C., Lopez-Barrera, F., Morales-Tlalpan, V., et al. 16 K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology 145:12 (2004), 5714–5722.
25. 25 Mahmood, T., Yang, P.C., Western blot: technique, theory, and trouble shooting. North Am J Med Sci 4:9 (2012), 429–434.
26. 26 Bryan, N.S., Grisham, M.B., Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med 43:5 (2007), 645–657.
27. 27 Miranda, K.M., Espey, M.G., Wink, D.A., A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:1 (2001), 62–71.
28. 28 Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:2 (1979), 351–358.
29. 29 van Essen, H.F., Verdaasdonk, M.A., Elshof, S.M., de Weger, R.A., van Diest, P.J., Alcohol based tissue fixation as an alternative for formaldehyde: influence on immunohistochemistry. J Clin Pathol 63:12 (2010), 1090–1094.
30. 30 Ding, B.A., Pirone, A., Lenzi, C., Xiaoming, N., Baglini, A., Romboli, I., Histochemical features of the Muscovy duck small intestine during development. Tissue Cell 43:3 (2011), 190–195.
31. 31 Meléndrez, M.F., Cárdenas, G., Arbiol, J., Synthesis and characterization of gallium colloidal nanoparticles. J Colloid Interface Sci 346:2 (2010), 279–287.
32. 32 Moulder WFS, John F., Sobol, Peter E., Bomben, Keneth D., Handbook of X-Ray Photoelectron Spectroscopy. 1992, Physical Electronics Inc., Japan.
33. 33 Vassallo, P.F., Stefanon, I., Rossoni, L.V., Tucci, P.J., Vassallo, D.V., The left ventricular contractility of the rat heart is modulated by changes in flow and alpha 1-adrenoceptor stimulation. Braz J Med Biol Res 31:10 (1998), 1353–1359.
34. 34 Takahashi, H., Maehara, K., Onuki, N., Saito, T., Maruyama, Y., Decreased contractility of the left ventricle is induced by the neurotransmitter acetylcholine, but not by vagal stimulation in rats. Jpn Heart J 44:2 (2003), 257–270.
35. 35 Quyyumi, A.A., Dakak, N., Andrews, N.P., Gilligan, D.M., Panza, J.A., Cannon, R.O., Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation 92:3 (1995), 320–326.
36. 36 Kim, D.-Y., Suk Sung, J., Kim, M., Ghodake, G., Rapid production of silver nanoparticles at large-scale using gallic acid and their antibacterial assessment. Mater Lett 155 (2015), 62–64.
37. 37 Razavian, M.H., Masaimanesh, M., Ingestion of silver nanoparticles leads to changes in blood parameters. Nanomed J 1:5 (2014), 339–345.
38. 38 Kojda, G., Kottenberg, K., Regulation of basal myocardial function by NO. Cardiovasc Res 41:3 (1999), 514–523.
39. 39 Lodish, H., Berk, A., Zipursky, S.L., Matsudaira, P., Baltimore, D., Darnell, J., Muscle: a Specialized Contractile Machine. 2000.
40. 40 Albanese, A., Tang, P.S., Chan, W.C., The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14 (2012), 1–16.
41. 41 Müller-Strahl, G., Kottenberg, K., Zimmer, H.G., Noack, E., Kojda, G., Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart. J Physiol 522:Pt 2 (2000), 311–320.
42. 42 Chen, Y., Traverse, J.H., Du, R., Hou, M., Bache, R.J., Nitric oxide modulates myocardial oxygen consumption in the failing heart. Circulation 106:2 (2002), 273–279.
43. 43 Marnett, L.J., Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res 424:1–2 (1999), 83–95.
44. 44 van der Loo, B., Bachschmid, M., Labugger, R., Schildknecht, S., Kilo, J., Hahn, R., et al. Expression and activity patterns of nitric oxide synthases and antioxidant enzymes reveal a substantial heterogeneity between cardiac and vascular aging in the rat. Biogerontology 6:5 (2005), 325–334.
45. 45 Kohen, R., Nyska, A., Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30:6 (2002), 620–650.
46. 46 Choi, J.E., Kim, S., Ahn, J.H., Youn, P., Kang, J.S., Park, K., et al. Induction of oxidative stress and apoptosis by silver nanoparticles in the liver of adult zebrafish. Aquat Toxicol 100:2 (2010), 151–159.
47. 47 Adeyemi, O.S., Faniyan, T.O., Antioxidant status of rats administered silver nanoparticles orally. J Taibah Univ Med Sci 9:3 (2014), 182–186.
48. 48 Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T., Mazur, M., Telser, J., Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:1 (2007), 44–84.
49. 49 Hunter, J.D., Gregg, K., Damani, Z., Rhabdomyolysis. Contin Educ Anaesth Crit Care Pain 6:4 (2006), 141–143.
50. 50 Torres, P.A., Helmstetter, J.A., Kaye, A.M., Kaye, A.D., Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J 15:1 (2015), 58–69.
51. 51 Al-Ismaili, Z., Piccioni, M., Zappitelli, M., Rhabdomyolysis: pathogenesis of renal injury and management. Pediatr Nephrol 26:10 (2011), 1781–1788.
52. 52 Vanholder, R., Sever, M.S., Erek, E., Lameire, N., Rhabdomyolysis. J Am Soc Nephrol 11:8 (2000), 1553–1561.
53. 53 Kennedy, D.C., Tay, L.-L., Lyn, R.K., Rouleau, Y., Hulse, J., Pezacki, J.P., Nanoscale aggregation of cellular β2-adrenergic receptors measured by plasmonic interactions of functionalized nanoparticles. ACS Nano 3:8 (2009), 2329–2339.
54. 54 Torp, K.D., Tschakovsky, M.E., Halliwill, J.R., Minson, C.T., Joyner, M.J., Beta-receptor agonist activity of phenylephrine in the human forearm. J Appl Physiol (1985) 90:5 (2001), 1855–1859.
55. 55 Ramirez-Lee, M.A., Rosas-Hernandez, H., Salazar-Garcia, S., Gutierrez-Hernandez, J.M., Espinosa-Tanguma, R., Gonzalez, F.J., et al. Silver nanoparticles induce anti-proliferative effects on airway smooth muscle cells. Role of nitric oxide and muscarinic receptor signaling pathway. Toxicol Lett 224:2 (2014), 246–256.
56. 56 Gonzalez, C., Salazar-Garcia, S., Palestino, G., Martinez-Cuevas, P.P., Ramirez-Lee, M.A., Jurado-Manzano, B.B., et al. Effect of 45 nm silver nanoparticles (AgNPs) upon the smooth muscle of rat trachea: role of nitric oxide. Toxicol Lett 207:3 (2011), 306–313.
57. 57 Wideman, R.F. Jr., Erf, G.F., Intravenous micro-particle injection and pulmonary hypertension in broiler chickens: cardio-pulmonary hemodynamic responses. Poult Sci 81:6 (2002), 877–886.
58. 58 Pieters, N., Koppen, G., Van Poppel, M., De Prins, S., Cox, B., Dons, E., et al. Blood pressure and same-day exposure to air pollution at school: associations with Nano-sized to coarse PM in children. Environ Health Perspect 123:7 (2015), 737–742.
59. 59 Benn, T.M., Westerhoff, P., Nanoparticle silver released into water from commercially available sock fabrics. Environ Sci Technol 42:11 (2008), 4133–4139.
60. 60 Bell, R.M., Mocanu, M.M., Yellon, D.M., Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. J Mol Cell Cardiol 50:6 (2011), 940–950.